Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Blocking LFA-1 prevents hair loss in mice.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Infliximab may cause hair loss in Crohn's disease patients.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Patients with Type 1 diabetes should be screened for pernicious anemia.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Adalimumab may cause severe hair loss in some patients.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Blocking certain proteins on immune cells may help treat alopecia areata.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.